Patents by Inventor Muhammad Baluom

Muhammad Baluom has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Controlled release oral drug delivery system
    Patent number: 7189414
    Abstract: The invention relates to synchronous drug delivery composition comprising a polymeric matrix which comprises hydrogel blended with a hydrophobic polymer, so as to form an erodible matrix, a drug, and, optionally, an agent which enhances intestinal drug absorption and/or an agent which inhibits intestinal drug degradation, wherein erosion of the erodible matrix, permits synchronous release of the drug, the hydrogel and the intestinal drug absorption agent and/or the agent which inhibits intestinal drug degradation.
    Type: Grant
    Filed: July 31, 2003
    Date of Patent: March 13, 2007
    Assignee: Yissum Research Development Company of the Hebrew University of Jerusalem
    Inventors: Abraham Rubinstein, Michael Friedman, Muhammad Baluom, Boaz Tirosh
  • Controlled release oral drug delivery system
    Publication number: 20040219216
    Abstract: The invention relates to synchronous drug delivery composition comprising a polymeric matrix which comprises hydrogel blended with a hydrophobic polymer, so as to form an erodible matrix, a drug, and, optionally, an agent which enhances intestinal drug absorption and/or an agent which inhibits intestinal drug degradation,
    Type: Application
    Filed: July 31, 2003
    Publication date: November 4, 2004
    Inventors: Abraham Rubinstein, Michael Friedman, Muhammad Baluom, Boaz Tirosh
  • Controlled release oral drug delivery system
    Publication number: 20040185107
    Abstract: The invention relates to synchronous drug delivery composition comprising a polymeric matrix which comprises hydrogel blended with a hydrophobic polymer, so as to form an erodible matrix, a drug, and, optionally, an agent which enhances intestinal drug absorption and/or an agent which inhibits intestinal drug degradation,
    Type: Application
    Filed: July 31, 2003
    Publication date: September 23, 2004
    Inventors: Abraham Rubinstein, Michael Friedman, Muhammad Baluom, Boaz Tirosh
  • Controlled release oral drug delivery system
    Patent number: 6692766
    Abstract: The present invention relates to a controlled release drug delivery system comprising a drug which is susceptible to enzymatic degradation by enzymes present in the intestinal tract; and a polymeric matrix which undergoes erosion in the gastrointestinal tract comprising a hydrogel-forming polymer selected from the group consisting of (a) polymers which are themselves capable of enhancing absorption of said drug across the intestinal mucosal tissues and of inbihiting degradation of said drug by intestinal enzymes; and (b) polymers which are not themselves capable of enhancing absorption of said drug across the intestinal mucosal tissues and of inhibiting degradation of said drug by intestinal enzymes; wherein when the matrix comprises a polymer belonging to group (b) the delivery system further comprises an agent which enhances absorption of said drug across the intestinal mucosal tissues and/or an agent which inhibits degradation of said drug by intestinal enzymes and when the matrix comprises a polymer belon
    Type: Grant
    Filed: February 28, 1997
    Date of Patent: February 17, 2004
    Assignee: Yissum Research Development Company of The Hebrew University of Jerusalem
    Inventors: Abraham Rubinstein, Raphael Radai, Michael Friedman, Boaz Tirosh, Muhammad Baluom, Taher Nassar